Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025)
Cyclerion Therapeutics (CYCN) posted quarterly Other Non Operating Income of $30000.0 for Q3 2025, down 28.57% year-over-year from $42000.0 in Q3 2024, and down 3.23% quarter-over-quarter from $31000.0 in Q2 2025.
Cyclerion Therapeutics (CYCN) Other Non Operating Income (2023 - 2025) Analysis & Trends
Cyclerion Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $30000.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 28.57% year-over-year to $30000.0; the TTM figure through Sep 2025 stood at $117000.0 (down 58.36% YoY), while the FY2024 annual figure was $208000.0, down 41.9% from the prior year.
- Other Non Operating Income for Q3 2025 stood at $30000.0, down from $31000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $107000.0 in Q3 2023, with the low at $28000.0 in Q4 2024.
- The 3-year median for Other Non Operating Income is $42000.0 (2024), against an average of $56111.1.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 72.28% in 2024, then slipped 28.57% in 2025.
- Cyclerion Therapeutics' Other Non Operating Income stood at $101000.0 in 2023, then plunged by 72.28% to $28000.0 in 2024, then increased by 7.14% to $30000.0 in 2025.
- Business Quant data shows CYCN's Other Non Operating Income at $30000.0 in Q3 2025, $31000.0 in Q2 2025, and $28000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cyclerion Therapeutics | 12.71 Mn | 9.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 76,000.00 |
| Dec 31, 2023 | 101,000.00 |
| Sep 30, 2023 | 107,000.00 |